6.5% CAGR of Healthcare Distribution Market Growth Forecast Report 2020

"The healthcare distribution market is projected to grow at a CAGR of 6.5% during the forecast period of 2019 to 2024"

ReportsnReports added a new report on The Healthcare Distribution Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. In-depth study on the current state which focuses on the major drivers and restraints for the key players. Healthcare Distribution Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts, geographic regions of the market and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Healthcare Distribution Market.

Download FREE PDF sample of this Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2299755

This report analyzes the healthcare distribution market and aims at estimating the size and future growth potential of this market as well as its segments. The report also includes an in-depth competitive analysis of the key players operating in this market, along with their company profiles, solution& service offerings, and recent developments.

The prominent players operating in this market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), Key Source Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), MutualDrug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).

The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024 from USD 765.4 billion in 2019, at a CAGR of 6.5%. The growth of this market is primarily driven by the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry. In addition, emerging markets such as China and India, growth in the biosimilars market, increasing specialty drug dispensing, and the rising uptake of biopharmaceuticals are expected to offer potential growth opportunities to market players in the coming years. However, increasing pricing pressure is a major challenge faced by market players.

Based on type, the healthcare distribution market is segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In 2018, the pharmaceutical product distribution services segment accounted for the largest share of this market owing to the increasing production of pharmaceutical formulations, rising pharmaceutical R&D expenditure, outsourcing of pharmaceutical manufacturing to Asian countries, and the establishment of new manufacturing facilitates by global pharmaceutical giants in newer geographies.

The retail pharmacies segment accounted for the largest share of the market in 2018. These pharmacies deal with a large volume of prescriptions on a daily basis. Moreover, in the US and other developed countries, the implementation of programs to ensure affordable healthcare for citizens has significantly increased the volume of prescriptions in retail pharmacies.

APAC market to witness the highest growth during the forecast period

North America accounted for the largest share of the global healthcare distribution market in 2018, followed by Europe. However, the APAC market is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to the growing regulatory requirements in the healthcare industries of several APAC countries to maintain compliance with good manufacturing and distribution practices and the rising number of pharmaceutical and biotechnology companies in the region. China and India are the fastest-growing markets in this region primarily due to the expanding pharmaceutical industries in these countries and the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs (as they move from manufacturing to the consumer).

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-55%, Tier 2-25%, and Tier 3-20%
By Designation: C-level-43%, Director-level-32%, and Others-25%
By Region: North America-38%, Europe-29%, Asia Pacific-23%,and the Rest of the World-10%

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=2299755

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

Market Penetration: Comprehensive information on the solution/service portfolios offered by the top players in the healthcare distribution market
Solution& Service Development/Innovation: Detailed insights on the upcoming trends, and solution and service launches in the healthcare distribution market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new solutions and services, growing geographies, and recent developments in the global healthcare distribution market
Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and solution& service offerings of the leading players operating in the healthcare distribution market

Table of Contents in this Report-

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Healthcare Distribution Services: Market Overview
4.2 North America: Healthcare Distribution Services Market, By Type (2018)
4.3 Europe: Healthcare Distribution Services Market, By End User (2018)
4.4 Healthcare Distribution Services Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence and Large Economic Burden of Chronic Diseases
5.2.1.2 Favorable R&D Investment Scenario and Subsequent Increase in Drug Launches
5.2.1.3 Growth of Track & Trace Solutions
5.2.1.4 Growing Importance of Generics
5.2.1.5 Growth of the Medical Devices Industry
5.2.2 Opportunities
5.2.2.1 Growth in the Biosimilars Market
5.2.2.2 Emerging Markets
5.2.2.3 Increasing Specialty Drug Dispensing
5.2.2.4 Increasing Uptake of Biopharmaceuticals
5.2.3 Challenges
5.2.3.1 Pricing Pressures

6 Healthcare Distribution Services Market, By Type
6.1 Introduction
6.2 Pharmaceutical Product Distribution Services
6.2.1 Over-The-Counter Drugs/Vitamins
6.2.1.1 Sales of OTC Drugs have Risen Due to Innovations, Promotion of Self-Medication, and Increased Access
6.2.2 Brand-Name/Innovator Drugs
6.2.2.1 Rising Demand for Prescription Drugs to Support the Growth of This Market Segment
6.2.3 Generic Drugs
6.2.3.1 Government Initiatives for Promoting the Usage of Generics to Support the Growth of This Market Segment
6.3 Medical Device Distribution Services
6.4 Biopharmaceutical Product Distribution Services
6.4.1 Monoclonal Antibodies
6.4.1.1 Increasing Incidence of Cancer to Support the Growth of This Market Segment
6.4.2 Vaccines
6.4.2.1 Growing Prevalence of Infectious Diseases has Boosted Vaccine Development
6.4.3 Recombinant Proteins
6.4.3.1 Growing Applications of Recombinant Proteins in Biopharmaceuticals to Drive the Growth of This Market Segment
6.4.4 Blood and Blood Products
6.4.4.1 Increasing Number of Blood Donations and Blood Transfusions to Support the Growth of This Market Segment
6.4.5 Other Products

7 Healthcare Distribution Services Market, By End User
7.1 Introduction
7.2 Retail Pharmacies
7.2.1 Large Volume of Prescriptions to Increase the Demand for Healthcare Distribution Services
7.3 Hospital Pharmacies
7.3.1 Significant Number of Inpatient Visits and Requirement of Large Volume of Drugs By Hospitals to Drive the Healthcare Distribution Services Market for Hospital Pharmacies
7.4 Other End Users

8 Healthcare Distribution Services Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 US Dominates the North American Healthcare Distribution Services Market
8.2.2 Canada
8.2.2.1 Rising Prevalence of Chronic Diseases and Increasing Market for Specialty Drugs Will Drive Market Growth in Canada
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany Accounted for the Largest Share of the European Healthcare Distribution Services Market in 2018
8.3.2 France
8.3.2.1 Presence of Leading Pharmaceutical Companies in the Country Will Drive Market Growth in France
8.3.3 UK
8.3.3.1 Growth in the Pharmaceuticals Market and Increase in Research Activity Will Drive Market Growth in the UK
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China and India are the Fastest-Growing Markets in the APAC
8.5 Rest of the World

9 Competitive Landscape
9.1 Introduction
9.2 Healthcare Distribution Services Market Share Analysis (2018)
9.3 Competitive Scenario

and more...

Contact us:
ReportsnReports
+ 1 888 391 5441
Email: sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.